GSK plc position in NKTX
NKARTA INC · Health Care
GSK plc reported holding 3,150,732 shares of NKTX (NKARTA INC) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 1.66% of its reported portfolio and ranking #9 among its reported holdings. GSK plc has disclosed NKTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR
How GSK plc's NKTX position evolved
GSK plc first disclosed a stake in NKTX in Q4 2025 at 3,150,732 shares (US$5.8M). The position peaked in Q2 2026 at 3,150,732 shares, worth US$8.9M. Across 4 filings, GSK plc held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,150,732 shares valued at US$8.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 3.15M | $5.83M | New |
| Q1 2026 | 3.15M | $6.65M | Hold |
| Q2 2026 | 3.15M | $8.92M | Hold |
| Q3 2026 | 3.15M | $8.25M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NKTX and 13F data
NKTX (NKARTA INC) is a Health Care company. 28 other funds we track also report a position in NKTX — the largest reported positions include NEA Management Company, LLC (US$10.1M), Samsara BioCapital, LLC (US$9.9M), SR ONE CAPITAL MANAGEMENT, LP (US$9.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NKTX
- NEA Management Company, LLC 3.57M sh · $10.10M · Q2 2026
- Samsara BioCapital, LLC 3.51M sh · $9.93M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 3.33M sh · $9.43M · Q2 2026
- Monaco Asset Management SAM 2.37M sh · $6.72M · Q2 2026
- Peapod Lane Capital LLC 518.41K sh · $1.36M · Q3 2026
FAQ
How long has GSK plc held NKTX?
GSK plc has disclosed NKTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is GSK plc's current position in NKTX?
As of Q3 2026, GSK plc holds 3.15M shares of NKTX (NKARTA INC), valued at $8.25M, representing 1.66% of its reported portfolio and ranking #9.
Has GSK plc been buying or selling NKTX?
In the latest 13F filing (Q3 2026), GSK plc held unchanged its position in NKTX. The position peaked in Q2 2026 at 3.15M shares.
Which other funds hold NKTX?
Other major institutional holders of NKTX include NEA Management Company, LLC, Samsara BioCapital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.